Perrigo
This article was originally published in The Rose Sheet
Executive Summary
Private label manufacturer expects FDA tentative approval of its abbreviated new drug application for 5% minoxidil topical solution "well before" the three-year marketing exclusivity for Pharmacia & Upjohn expires Nov. 14, 2000. Alpharma's ANDA for private label version of P&U's Rogaine Extra Strength for Men was tentatively approved July 22 (1"The Rose Sheet" Aug. 2, In Brief)